Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19042026 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder
Conditions: Bipolar Disorder;   Anxiety Disorder
Intervention: Drug: Risperidone

Indicates status has not been verified in more than two years